Cancer
Neoplasm of Uncertain Histogenesis
CI-CAN-00000034Explore in graph →
Non-malignant20,272 active trials259 approved drugs3,813 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00000034Explore in graph →
Clinical trials
91,327 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05851755 | Italian Lung Cancer Observational Study(LUCENT) | enrolling by invitation | — | 1,000 | The Mediterranean Institute for Transplantation and Advanced Specialized TherapiesOTHER | 1 | May 10, 2023 | clinicaltrials |
| NCT05740111 | The PREPAIRD Study: Personalized Surveillance for Early Detection of Pancreatic Cancer in High Risk Individuals(PREPAIRD) | enrolling by invitation | N/A | 200 | Oslo University Hospital |
| 1 |
| Feb 22, 2023 |
| clinicaltrials |
| NCT05171335 | Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients | enrolling by invitation | Phase 2 | 50 | The Methodist Hospital Research InstituteOTHER | 1 | Sep 21, 2022 | clinicaltrials |
| NCT05528237 | HPV Self-sampling to Improve Access to Cervical Cancer Screening for Persons With HIV and/or Underserved Individuals(ACCESS) | enrolling by invitation | N/A | 50 | University of WashingtonOTHER | 1 | Sep 6, 2022 | clinicaltrials |
| NCT04762459 | Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage II-IIIA Non-small Cell Lung Carcinoma Following Complete Tumour Resection(APEX) | enrolling by invitation | Phase 3 | 606 | Chinese Academy of Medical SciencesOTHER | 1 | Feb 24, 2022 | clinicaltrials |
| NCT05213962 | Local and Regional Radiotherapy for Nipple Sparing Mastectomy With Implant | enrolling by invitation | — | 128 | National Cancer Center, KoreaOTHER_GOV | 1 | Jan 28, 2022 | clinicaltrials |
| NCT04203849 | Prospective Cohort Study of Breast Cancer Patients Treated With Radiotherapy | enrolling by invitation | — | 5,000 | National Cancer Center, KoreaOTHER_GOV | 1 | Dec 22, 2021 | clinicaltrials |
| NCT04488614 | Prospective Breast Cancer Biobanking(PBCB) | enrolling by invitation | — | 1,200 | Helse Stavanger HFOTHER_GOV | 1 | Jul 30, 2020 | clinicaltrials |
| NCT04491721 | Follow-up the OS and PFS of Rituximab Biosimilar HLX01 and MabThera, in Untreated Subjects With CD20+ DLBCL | enrolling by invitation | — | 407 | Chinese Academy of Medical SciencesOTHER | 1 | Jul 29, 2020 | clinicaltrials |
| NCT04466124 | Prospective Cohort Study of Liver Cancer Patients Treated With Proton Beam Therapy | enrolling by invitation | — | 500 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 13, 2020 | clinicaltrials |
| NCT04466189 | Prospective Cohort Study of Pancreatic Cancer Patients Treated With Proton Beam Therapy | enrolling by invitation | — | 120 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 13, 2020 | clinicaltrials |
| NCT03474237 | A Prospective Cohort Study for Patients With Adrenal Diseases | enrolling by invitation | — | 1,500 | Seoul National University HospitalOTHER | 1 | Mar 18, 2020 | clinicaltrials |
| NCT03815279 | A Nationwide Phase 2 Trial of Patients With Smoldering and Active Multiple Myeloma (MM)(iStopMM) | enrolling by invitation | Phase 2 | 80 | Landspitali University HospitalOTHER | 1 | Aug 16, 2019 | clinicaltrials |
Data updated 23 days agoSource updated May 10, 2023source: clinicaltrials